Effects of Different Weak Small Organic Acids on Clofazimine Solubility in Aqueous Media

Igor A. Topalović,Olivera S. Marković,Miloš P. Pešić,Mufaddal H. Kathawala,Martin Kuentz,Alex Avdeef,Abu T. M. Serajuddin,Tatjana Ž. Verbić
DOI: https://doi.org/10.3390/pharmaceutics16121545
IF: 6.525
2024-12-03
Pharmaceutics
Abstract:Background/Objectives: Clofazimine (CFZ) is a Biopharmaceutics Classification System (BCS) II drug introduced in the US market in 1986 for the treatment of leprosy. However, CFZ was later withdrawn from the market due to its extremely low aqueous solubility and low absorption. In the literature, the intrinsic solubility of CFZ has been estimated to be <0.01 μg/mL, and solubilities of its different salt forms in simulated gastric and intestinal fluids are 10 mg/mL in the presence of 5 M glutaric acid could be called supersolubilization when compared to the intrinsic solubility of the basic drug. Such an increase in CFZ solubility and the conversion of the glutarate adduct to an amorphous state are being exploited to develop rapidly dissolving dosage forms.
pharmacology & pharmacy
What problem does this paper attempt to address?